Cite
MLA Citation
K. Callis Duffin et al.. “Phase 3, open‐label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate‐to‐severe plaque psoriasis (UNCOVER‐A).” Journal of the European Academy of Dermatology and Venereology, vol. 31, n.d., pp. 107–113. http://access.bl.uk/ark:/81055/vdc_100039856807.0x000036